Log In
BCIQ
Print this Print this
 

INCB39110

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionJanus kinase-1 (JAK-1) inhibitor
Molecular Target Janus kinase-1 (JAK-1)
Mechanism of ActionJanus kinase-1 (JAK-1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsTreat acute graft-versus-host disease (GvHD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/11/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today